34.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
Melanoma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Algorithm, Pipeline Analysis | IO Biotech, Moderna Inc., Merck Sharp & Dohme LLC, BioNTech SE, TILT Biotherapeutics LLC, Nykode - Barchart.com
South Dakota Investment Council Lowers Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
What drives Moderna Inc. stock priceFree High-Return Strategy Alerts - jammulinksnews.com
Moderna (NASDAQ:MRNA) Given New $25.00 Price Target at Bank of America - MarketBeat
What analysts say about Moderna Inc. stockHigh-velocity gains - jammulinksnews.com
Moderna Inc. Stock Analysis and ForecastRapid profit acceleration - jammulinksnews.com
Moderna Target of Unusually High Options Trading (NASDAQ:MRNA) - MarketBeat
New York State Common Retirement Fund Sells 33,365 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Lexicography: Clear And Unequivocal - The National Law Review
Wealthfront Advisers LLC Purchases 18,268 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
After Moderna Pulled Its Shot, Combination Flu/COVID Vaccines Hang in Limbo - BioSpace
Moderna Bets Big On New Vaccines After Stock Tumbles - Finimize
Moderna, Inc. - Britannica
Equities Analysts Offer Predictions for Moderna Q2 Earnings - MarketBeat
Is Moderna Inc. a good long term investmentRobust investment performance - jammulinksnews.com
Edgestream Partners L.P. Has $2.78 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Buys 17,268 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Nisa Investment Advisors LLC - MarketBeat
Moderna, Inc. (MRNA) Aktienkurs, Nachrichten, Kurs und Verlauf - yahoo.co
Here's Why Moderna (MRNA) Fell More Than Broader Market - Yahoo Finance
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know - Yahoo Finance
How IBM and Moderna’s partnership could lead to an explosion in drug development - Fast Company
Moderna cancels plans to build Japan plant on poor business environment - Reuters
Moderna gets full FDA approval for kids COVID-19 vaccine - MSN
Moderna, Inc.'s (NASDAQ:MRNA) Price Is Right But Growth Is Lacking After Shares Rocket 26% - simplywall.st
Moderna cancels mRNA production plant in Japan (MRNA:NASDAQ) - Seeking Alpha
Cwm LLC Purchases 28,831 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Lobbying Update: $120,000 of MODERNA INC. lobbying was just disclosed - Quiver Quantitative
Thursday's Notable Option Activity: Oracle, United Airlines, Moderna - AInvest
How IBM and Moderna (MRNA) Are Using Quantum Computing to Design Vaccines Faster - TipRanks
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 - Amarillo Globe-News
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease - Knoxville News Sentinel
IBM-Moderna Showcase Quantum-Enhanced Drug Discovery - HPCwire
IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine. - Barron's
Director, Strategic Forecasting, Oncology job with Moderna, Inc. | 1402245670 - New Scientist
Moderna’s latest approval again reveals FDA rift over COVID vaccines - BioPharma Dive
Bank of New York Mellon Corp Purchases 34,034 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
FDA Fully Approves Moderna’s COVID-19 Vaccine for Some Young Children - Vaccine Advisor
Lobbying Update: $100,000 of MODERNA US INC. lobbying was just disclosed - Quiver Quantitative
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):